• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

American Medical Association Opposes FDA Blood Donation Ban for Gay Men

July 3, 2013

The American Medical Association (AMA) voted June 18th to oppose the United States Food and Drug Administration’s (FDA) lifetime ban on blood donations from men who have sex with men (MSM). The AMA policy also called for the use of evidence-based and consistent methods in deferring blood donors. The FDA currently prohibits men who have had sex with men at any time since 1977 from donating blood. The AMA, however, suggests that the lifetime ban on blood donation from MSM is discriminatory, and that deferrals should be established according to an individual’s risk, but not on sexual orientation alone. Donated blood is routinely tested for HIV in the United States. The risk of transfusion-transmitted HIV is 1 per 2 million units of blood.

 

 

 

 

 

References

1.    American Medical Association. AMA Adopts New Policies on Second Day of Voting at Annual Meeting. June 18, 2013. Accessed July 1, 2013.

http://www.ama-assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page

2.    U.S. Food and Drug Administration. Blood Donations from Men Who Have Sex with Other Men Questions and Answers.  Accessed July 1, 2013.

http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/QuestionsaboutBlood/ucm108186.htm

 

Filed Under

  • Blood Donation
  • News
  • Policy and Guidelines
  • Quality Control and Regulatory

Recommended

  • Surveys Report Fewer Blood Collections and Transfusions in 2013

  • Recombinant von Willebrand Factor and Tranexamic Acid for Menstruating Women with von Willebrand Disease

  • The FDA Approves Cerus’s Intercept System for Platelets and Plasma

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley